MAP2K7 and cancer: Indeed, we observed broad synergistic effects for BET/MEK combinations across cancer models, which we attribute to profound and sustained inhibition of MEK/ERK signaling that is specifically observed with the combination ultimately leading to growth arrest and cell death.